Media Pack
News

Current Edition

JCS Volume 15 Issue 3
 
US Enhances Malaria-fighting Toolkit
Volume 10 Issue 5

US Enhances Malaria-fighting Toolkit

The (FDA) asked an advisory committee to meet twice in two weeks to discuss nearly identical products with similar indications from two different pharmaceutical compa...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Innovative Approaches in Early-phase and First in Human Clinical Trials
Volume 10 Issue 5

Innovative Approaches in Early-phase and First in Human Clinical Trials

There are many challenges that clinical research may face, and there is a risk of failure along the many phases of development. For a trial designer, there are many i...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Harnessing Social Media to Reach Today’s Social Media-savvy Rare Disease Patient and Caregiver
Volume 10 Issue 5

Harnessing Social Media to Reach Today’s Social Media-savvy Rare Disease Patient and Caregiver

For patients with rare diseases, social media conversations are a gateway to uncovering information regarding condition coping and treatment. Likewise, for those who ...
25 October 2018 Volume 10 Issue 5
Continue Reading →
An Interprofessional Model for Cardiac Safety Education
Volume 10 Issue 5

An Interprofessional Model for Cardiac Safety Education

Since its formalisation in 2006, the Cardiac Safety Research Consortium (CSRC) has facilitated research projects, think tanks, and many publications in medical and sc...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Diabetes Research Using New Data Models Makes Fresh Research Connections
Volume 10 Issue 5

Diabetes Research Using New Data Models Makes Fresh Research Connections

The emergence of Big Data and other advances in data science approaches and tools are providing medical researchers with the opportunity for previously unobtainable i...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Pharmacovigilance in the European Union
Volume 10 Issue 5

Pharmacovigilance in the European Union

In 2012, the European Union (EU) introduced regulatory controls for good pharmacovigilance practices (GVPs) to its member states. Since then, pharma businesses operat...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Landscape of Early-phase Oncology Studies in the Netherlands
Volume 10 Issue 5

Landscape of Early-phase Oncology Studies in the Netherlands

The Netherlands has been a natural favourite for conducting clinical research with the Dutch healthcare system ranking among the best in Europe, the high level of edu...
25 October 2018 Volume 10 Issue 5
Continue Reading →
The Journey to Clinic and Beyond
Volume 10 Issue 5

The Journey to Clinic and Beyond

The formulation of a candidate drug for first in human (FIH) trials is of great importance – how a pharmaceutical company chooses to approach this challenge can ultim...
25 October 2018 Volume 10 Issue 5
Continue Reading →
Clinical Development in Rare Diseases: Idiopathic Pulmonary Fibrosis
Volume 10 Issue 5

Clinical Development in Rare Diseases: Idiopathic Pulmonary Fibrosis

IPF is a rare disease, in which patients are most often affected from middle age, and its manifestation is characterised by severe, irreversible interstitial fibrosis...
25 October 2018 Volume 10 Issue 5
Continue Reading →
The Evolving Clinical Trial Landscape in Amyotrophic Lateral Sclerosis
Volume 10 Issue 5

The Evolving Clinical Trial Landscape in Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis is a neurodegenerative disorder affecting predominantly central and peripheral motor neurons, resulting in progressive weakness and atro...
25 October 2018 Volume 10 Issue 5
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2023, All Rights Reserved – Powered by Teksyte